Scott Houlton
CEO Advisory Board Member
Scott Houlton is the CEO of MLM (GPP III) and on the board of Tergus (GPP III).
In 2016, Mr. Houlton joined Clinical Supplies Management (“CSM”) as CEO, completed two European tuck-ins, tripled revenues and in September 2018, led the sale of the business to Clinigen, which resulted in a 4.9x multiple of invested capital and 125% IRR for GPP. Prior to joining CSM, he was President, Development & Clinical Services and an Officer at Catalent, Inc.
Mr. Houlton graduated cum laude with a Bachelor’s degree in Finance and in International Business from The Ohio State University.